y 27632 has been researched along with orantinib in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 110 | 19 | 36 |
| Protein | Taxonomy | y 27632 (IC50) | orantinib (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 2.186 | |
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 3.6 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 1.126 | |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | 3.003 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.028 | |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | 3.6 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 1.8986 | |
| Aurora kinase B | Homo sapiens (human) | 0.041 | |
| Aurora kinase C | Homo sapiens (human) | 0.21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
1 other study(ies) available for y 27632 and orantinib
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |